Current research on the immunomodulatory effect of allogeneic blood transfusion

Vox Sanguinis

Volumn 70, Issue 4, 1996, Pages 187-194

  Dzik, Sunny ^a,b   Blajchman, Morris A ^c,d   Blumberg, Neil ^e,f   Kirkley, Scott A ^e,f   Heal, Joanna M ^e,f   Wood, Kathryn ^g  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d Canadian Red Cross Society   (Canada)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f AMERICAN RED CROSS BLOOD SERVICES   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD TRANSFUSION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOMODULATION; INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR RECURRENCE;

EID: 0030013346     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1996.tb01324.x     Document Type: Review

References (56)

1. Billingham RE, Brent L, Medawar PB: 'Actively acquired tolerance' of foreign cells. Nature 1953;172:603-606.
2. Shelby J, Wakely E, Cory R: Splenectomy abrogates the improved graft survival achieved by donor-specific transfusion. Transplant Proc 1985;17:1083-1086.
3. Wood KJ: Antigen induced tolerance; in Ildstad ST (ed): Chimerism and Tolerance. Austin, Landes, 1995, pp 15-29.
4. Campos L, Alfrey EJ, Posselt AM, et al: Prolonged survival of rat orthotopic liver allografts after intrathymic inoculation of donor-strain cells. Transplantation 1993;55:866-870.
5. James T, Jin MX, Chowdhury NC, Oluwole SF: Tolerance induction to rat islet allografts by intrathymic inoculation of donor spleen cells. Transplantation 1993;56:1148-1152.
6. Sayegh MH, Perico N, Gallon L, Imberti O, Hancock WW, Remuzzi G, Carpenter CB: Mechanisms of acquired thymic unresponsiveness to renal allografts. Transplantation 1994; 58:125-132.
7. Knechtle SJ, Shoushu JW, Geissler EK, Sumimoto R, Wolff J: Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 1994; 57:990-996.
8. Busch MP, Lee TH, Donegan E, Pallavicini M: Use of an inbred model system for studies of allogeneic transfusion-induced immunosuppression. Blood 1993;82:3509-3510.
9. Adams PT, Davenport RD, Reardon DA, Roth MS: Detection of circulating donor white blood cells in patients receiving multiple blood transfusions. Blood 1992;80:551-555.
10. Thomas JM, Thomas FT: A preclinical view of transplant tolerance and chimerism: Tolerance induction by posttransplant lymphoid irradiation and donor bone marrow; in Ildstad ST (ed): Chimerism and Tolerance. Austin, Landes, 1995, pp 143-158.
11. Thomas JM, Verbanac KM, Smith JP, et al: The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation 1995;59:245-255.
12. Shirwadkar S, Blajchman MA, Frame B, Orr RW, Singal DP: Effect of blood transfusions on experimental pulmonary metastases in mice. Transfusion 1990;30:188-190.
13. Shirwadkar S, Blajchman MA, Frame B, Singal DP: Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice. J Cancer Res Clin Oncol 1992;118: 176-180.
14. Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP: Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993;81:1880-1882.
15. Blajchman MA, Bordin JO: Mechanisms of transfusion-related immunosuppression. Curr Opin Hematol 1994;1:457-461.
16. Bordin JO, Bardossy L, Blajchman MA: Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of timing of the leukodepletion. Blood 1994;84:344-348.
17. Blajchman MA, Bordin JO: Tumor growth-promoting effect of allogeneic transfusion. Immunol Invest 1995;24:311-317.
18. Goldman M, Frame B, Singal DP, Blajchman MA: Effect of blood transfusion on survival in a mouse bacterial peritonitis model. Transfusion 1991;31:710-712.
19. Munson JL, van Twuyver E, Mooijaart RJD, Roux E, ten Berge IJM, de Waal LP: Missing T-cell receptor Vβ families following blood transfusion: The role of HLA in development of immunization and tolerance. Hum Immunol 1995;42:43-53.
20. Sheng-Tanner X, Miller RG: Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. J Exp Med 1992;176:407-413.
21. Thomas JM, Carver FM, Cunningham PRG, Olson LC, Thomas FT: Kidney allograft tolerance in primates without chronic immunosuppression - The role of veto cells. Transplantation 1991;51:198-207.
22. Jensen LS, Andersen AJ, Christiansen PM, et al: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-516.
23. Maki T, Simpson M, Monaco AP: Development of suppressor T cells by antilymphocyte serum treatment in mice. Transplantation 1982;34: 376-381.
24. Leivestad T, Thorsby E: Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness. Transplantation 1984; 37:175-181.
25. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB: Cytokines and the Th1/ Th2 paradigm in transplantation. Curr Opin Immunol 1994;6:757-764.
26. Dallman MJ, Larsen CP, Morris PJ: Cytokine gene transcription in vascularized organ grafts: Analysis using semiquantitative polymerase chain reaction. J Exp Med 1991;174:493-496.
27. Lowry RP, Takeuchi T: The Th1, Th2 Paradigm and Transplant Tolerance. Austin, Landes, 1994.
28. Bugeon L, Cuturi MC, Hallet MM, Paineau J, Chabannes D, Soulillou JP: Peripheral tolerance of an allograft in adult rats - Characterization by low interleukin-2 and interferon gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992;54: 219-225.
29. Kirkley SA, Cowles J, Pellegrini VD, Harris CM, Boyd AD, Blumberg N: Cytokine secretion after allogeneic or autologous blood transfusion. Lancet 1995;345:527.
30. Verbanac KM, Carver M, Haisch CE, Thomas JM: A role for transforming growth factor-beta (TGF-β) in the veto mechanism in transplant tolerance. Transplantation 1994;57:893-900.
31. Boussiotis VA, Gribben JG, Freeman GJ, Nadler LM: Blockade of the CD28 co-stimulatory pathway: A means to induce tolerance. Curr Opin Immunol 1994;6:797-807.
32. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993;151:1224-1234.
33. Madsen JC, Superina RA, Wood KJ, Morris PJ: Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988;332:161-164.
34. Bell Y, Shoskes D, Morris PJ, Wood KJ: Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: Evidence for indirect presentation of allopeptides in vivo. Transplant Proc 1993;25:359.
35. Morris PJ, Ting A, Stocker JW: Leucocyte antigens in renal transplantation: The paradox of blood transfusion in renal transplantation. Med J Aust 1968;2:1088-1090.
36. Madsen JC, Peugh WN, Wood KJ, Morris PJ: The effect of anti-L3T4 monoclonal antibody on first-set rejection of murine cardiac allografts. Transplantation 1987;44:849-852.
37. Pearson TC, Bushell AR, Darby CR, West LJ, Morris PJ, Wood KJ: Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Clin Exp Immunol 1993;92:211-217.
38. Wofsy D, Mayes DC, Woodcock J, Seaman WE: Inhibition of humor immunity in vivo by monoclonal antibody to L3T4: Studies with soluble antigens in intact mice. J Immunol 1985; 135:1698-1701.
39. Benjamin RJ, Waldmann H: Induction of tolerance by monoclonal antibody therapy. Nature 1986;320:449-451.
40. Pearson TC, Madsen JC, Larsen C, Morris PJ, Wood KJ: Induction of transplantation tolerance in the adult using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992;54:475-483.
41. Saitovitch D, Bushell A, Morris P, Wood KJ: Induction of transplantation tolerance using a nondepleting anti-CD4 mAb and donor specific transfusion before transplantation: Evidence that a critical period of time is required for the development of immunological unresponsiveness. Transplant Proc 1995;27:117-118.
42. Bushell A, Morris P, Wood KJ: Anti-CD4 antibody combined with random blood transfusion leads to authentic transplantation tolerance in the mouse: A protocol with significant clinical potential. Transplantation 1994;58:133-140.
43. Vamvakas E, Moore SB: Perioperative blood transfusion and colorectal cancer recurrence: A qualitative statistical overview and meta-analysis. Transfusion 1993;33:754-765.
44. Vamvakas EC, Moore SB: Blood transfusion and postoperative septic complications. Transfusion 1994;34:714-727.
45. Blumberg N, Heal JM, Chuang C, et al: Further evidence supporting a cause and effect relationship between blood transfusion and cancer recurrence. Ann Surg 1988;207:410-415.
46. Tartter PI, Driefuss RM, Malon AM, Heimann TM, Aufses AH: Relationship of postoperative septic complications and blood transfusion in patients with Crohn's disease. Am J Surg 1988; 155:43-17.
47. Murphy P, Heal JM, Blumberg N: Infection or suspected infection after hip replacement surgery with autologous or homologous transfusions. Transfusion 1991;31:212-217.
48. Triulzi DJ, Vanek K, Ryan DH, Blumberg N: A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992;32:517-524.
49. Murphy PJ, Connery C, Hicks GL, Blumberg N: Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1992;104:1092-1099.
50. Tartter PI: The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633-638.
51. Dodd RY: Adverse consequences of blood transfusion: Quantitative risk estimates; in Nance ST (ed): Blood Supply: Risks, Perceptions and Prospects for the Future. Bethesda, American Association of Blood Banks, 1994, pp 1-24.
52. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
53. Wood ML, Monaco AP, Gozzo JJ: Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: Dose and timing. Transplant Proc 1971;3:676-679.
54. McDaniel DO, Lagoo-Deenadayalan S, Barber WH: Donor-specific bone marrow infusion in renal allograft recipients; in Ildstad ST (ed): Chimerism and Tolerance. Austin, Landes, 1995, pp 129-141.
55. Sykes M, Sachs DH, Nienhuis AW, Pearson DA, Moulton AD, Bodine DM: Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 1993;55:197-202.
56. Risdon G, Gaddy J, Horie M, Broxmeyer HE: Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci 1995;92:2413-2417.